1. Prospects for the Development of New Treatments with a Rapid Onset of Action in Affective Disorders

   • Jair C. Soares
   • Samuel Gershon

   Current Opinion 13 October 2012 Pages: 477 - 482

2. Drug Treatment of Epilepsy in the 1990s

   • Anne Sabers
   • Lennart Gram

   Leading Article 13 October 2012 Pages: 483 - 493

3. Management of Gastrointestinal Motility Disorders

   • Juan-R. Malagelada
   • Eleonora Distrutti

   Disease Management 13 October 2012 Pages: 494 - 506

4. Intra- Articular Corticosteroids

   • Jacques R. Caldwell

   Disease Management 13 October 2012 Pages: 507 - 514

5. Recognition and Optimum Management of Myocarditis

   • Alida L. P. Caforio
   • William J. McKenna

   Disease Management 13 October 2012 Pages: 515 - 525

6. Common Ocular Infections

   • Sean P. Donahue
   • Johnny M. Khoury
   • Regis P. Kozvalski

   Disease Management 13 October 2012 Pages: 526 - 540

7. Erratum to Current status of dopamine agonists in Parkinson’s disease

   • J. L. Montastruc
   • O. Rascol
   • J. M. Senard

   Erratum 13 October 2012 Pages: 540 - 540

8. Erratum to Current status of dopamine agonists in Parkinson’s disease

   • K. L. Goa
   • A. J. Wagstaff

   Erratum 13 October 2012 Pages: 540 - 540

9. Ritonavir

   • Andrew P. Lea
   • Diana Faulds

   New Drug Profile 13 October 2012 Pages: 541 - 546

10. Ritonavir

    • Brian G. Gazzard

    New Drug Profile 13 October 2012 Pages: 547 - 547

11. Ritonavir

    • Hiroaki Mitsuya

    New Drug Profile 13 October 2012 Pages: 547 - 548

12. Riluzole

    • Harriet M. Bryson
    • Bret Fulton
    • Paul Benfield

    Drug Evaluation 13 October 2012 Pages: 549 - 563

13. Lisinopril

    • Karen L. Goa
    • Julia A. Balfour
    • Giulio Zuanetti

    Drug Evaluation 13 October 2012 Pages: 564 - 588

14. Reteplase

    • Stuart Noble
    • Donna McTavish

    Drug Evaluation 13 October 2012 Pages: 589 - 605

15. Irinotecan

    • Lynda R. Wiseman
    • Anthony Markham

    Drug Evaluation 13 October 2012 Pages: 606 - 623